SEC Filing Details
Document Details
Form
Filing Date
Jun 14, 2021
Document Date
Jun 10, 2021
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
CRISPR Therapeutics
Issuer
CRISPR Therapeutics AG
Filer
FLEMING HAROLD EDWARD